Say Hello!
Don’t be shy.

 
0333 323 1843
 

[email protected]

 

BioCity Group HQ:
Pennyfoot Street
Nottingham
NG1 1GF

XenoGesis Tag

Supporting the discovery and development of new therapeutics during the pandemic Nottingham-based contract research organisations (CROs) have strengthened their existing links to work together and support the discovery and development of new therapeutics during the pandemic. Many businesses have been impacted by the restrictions on the movement...

XenoGesis Founder and CEO, Richard Weaver, has been named Director of the Year at the Institute of Directors East Midlands Awards 2019, in the SME business (Small) category. Held at Winstanley House, Leicestershire, the awards celebrated the most dynamic and inspiring directors in the region. Forty-six of...

XenoGesis has appointed Dr Rachel Hemsley as global head of business development in a drive to support its ambitious growth plans. The Nottingham-based biotechnology company is the UK's largest independent laboratory-based contract research organisation (CRO) specialising in preclinical drug metabolism and pharmacokinetics (DMPK) – enabling it to provide expert...